Abstract
This letter to the editor outlines the global challenges posed by the multidrug-resistant yeast Candida auris. Highlighting its emergence, spread, and challenges in diagnosis and treatment, the letter emphasizes the rising prevalence, especially in the post- COVID-19 era. The geographical distribution, risk factors, and mortality rates are discussed, emphasizing the urgent need for a coordinated global response. The absence of a definitive management protocol and the high virulence of C. auris underscore the importance of preventive measures, targeted treatment, and ongoing research for innovative diagnostic techniques and antifungal drugs. The letter calls for a concerted effort among healthcare providers, researchers, and stakeholders to curb the spread of this emerging fungal pathogen.
Recommended Citation
Ali, Usman; Tareen, Hafsa Khan; Sarfraz, Zouina; Safraz, Azza; and Bano, Shehar
(2024)
"Act Now: The Global Threat of Candida Auris and the Urgent Need for Effective Countermeasures,"
Journal of Community Hospital Internal Medicine Perspectives: Vol. 14:
Iss.
2, Article 22.
DOI: 10.55729/2000-9666.1303
Available at:
https://scholarlycommons.gbmc.org/jchimp/vol14/iss2/22
